SIRT1 activation confers neuroprotection in experimental optic neuritis
about
Protective effects and mechanisms of sirtuins in the nervous systemAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionMammalian sirtuins: biological insights and disease relevanceOpposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activitySmall molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivoExpansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.Mitochondrial disorders and the eye.Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retinaSirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.A mechanism of virus-induced demyelination.The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye.Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Sirt3 protects cortical neurons against oxidative stress via regulating mitochondrial Ca2+ and mitochondrial biogenesis.HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?The influence of nutritional factors on the prognosis of multiple sclerosis.Differential expression of sirtuin family members in the developing, adult, and aged rat brain.Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosisInduction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene.Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressorsSIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in manInterplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus.Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection.SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70The importance of NAD in multiple sclerosisLipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stressSirtuin deacetylases as therapeutic targets in the nervous systemSIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating diseaseIn vivo detection of experimental optic neuritis by pupillometry.Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets
P2860
Q26825585-8D678E47-E73A-428A-910A-8BE451051DD4Q27487496-74A35175-1649-4FEC-ACB9-1240543040E8Q29614496-9FB97BB5-A055-4A29-B025-CBC03541D2DEQ33396651-636C64BC-A728-426B-8D90-C03222A2D5D2Q33417863-40626ED6-B9B5-469C-895A-8DD1F7DA4503Q33631820-6427CB00-01A8-4F37-B14D-F398B16AC2E9Q33702120-B9F9FCB2-411F-40D3-AD82-88BB8BAE6794Q33930338-70A498C2-6DCB-4B28-A3C9-FBC6751A95FAQ33986353-DBA67F4C-2A85-4421-B25B-77D3ADD6CED6Q34002984-F84EC66F-C876-412E-BC81-89396751DDDEQ34125724-70BC0537-86E4-41DF-BECF-1718B0BCF33EQ34152110-EBF4129D-BEF2-493D-A4C9-585AE4E8B8D9Q34158665-D3C4CF49-7B29-4270-A82E-D6BC4296E688Q34166691-3AD1DDC1-1014-40B6-9D86-8B0A8F0D7E84Q34344447-BCC49A78-08A0-4926-9085-6A34EF94C817Q34570124-A8D935F3-1F58-4565-925C-BC8D8AC70A24Q34643392-08196003-17E9-4547-9674-42A1D916E359Q34730013-0CE39B16-B68D-4E22-A9CC-5A79E35AB129Q35078252-169AB81A-4831-413B-A2E0-7F3A87A322BAQ35599430-FC1952CE-10ED-4225-8FF8-E0BC1B2DB471Q35854099-3D7358C1-8282-44CD-A2AC-B99CDEB0E249Q35985952-696B077F-B7AE-4906-8766-9E6E512E9793Q36099563-107A5F2B-9264-4686-A3DB-2662B20BE8E8Q36496948-5B3FD1BF-53D9-4763-ADBB-715534DB3160Q36562488-B1A99178-0D28-49D9-9A83-74FB5BEDE6A9Q36678075-7687BA4B-EDF2-4A5F-95F7-05E3B7253EB6Q36845899-03E098A4-EB75-4B62-BBFB-E8A35C0C9D59Q36913813-AEC05F03-9ABE-4319-ACCF-A8C8505BD510Q36929583-A5843918-C580-40C0-8049-3856695390F1Q37049075-F388327E-4086-4435-A59B-CCB329907990Q37053162-F14F6630-CEDB-4B43-9247-587C09E7BFA7Q37078409-54912681-D38B-4E79-B2F8-8B3790B3B64CQ37118012-ABA1A56F-D827-4CAB-8B61-8CC659C9668BQ37180260-493139A9-94AA-4AA4-918B-9846D2431304Q37245979-BF6A79FA-0122-4E10-BA01-9C8F547D709CQ37249172-08D7A31A-8C81-4E35-B62F-4CD28D6B9F50Q37480249-5BEE1DD4-7699-44CA-9229-A787A391E7EEQ37581931-BF12CEF4-CE54-4F4A-B40D-6AE0827ECED9Q37615358-C1EEF4F4-C95F-45D0-AF87-99C0F34B0160Q37657902-7B442DC8-7D77-4361-8304-1D8C9564A16A
P2860
SIRT1 activation confers neuroprotection in experimental optic neuritis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
SIRT1 activation confers neuroprotection in experimental optic neuritis
@ast
SIRT1 activation confers neuroprotection in experimental optic neuritis
@en
type
label
SIRT1 activation confers neuroprotection in experimental optic neuritis
@ast
SIRT1 activation confers neuroprotection in experimental optic neuritis
@en
prefLabel
SIRT1 activation confers neuroprotection in experimental optic neuritis
@ast
SIRT1 activation confers neuroprotection in experimental optic neuritis
@en
P2093
P2860
P356
P1476
SIRT1 activation confers neuroprotection in experimental optic neuritis
@en
P2093
Abdolmohamad Rostami
Elvira Ventura
Kenneth S Shindler
Peter Elliott
Tonia S Rex
P2860
P304
P356
10.1167/IOVS.07-0131
P407
P577
2007-08-01T00:00:00Z